Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition

The development and implementation of Immune Checkpoint Inhibitors (ICI) in clinical oncology have significantly improved the survival of a subset of cancer patients with metastatic disease previously considered uniformly lethal. However, the low response rates and the low number of patients with du...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelsen, Agnete S. T., Lotsberg, Maria L., Abou Khouzam, Raefa, Thiery, Jean-Paul, Lorens, James B., Chouaib, Salem, Terry, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092944/
https://www.ncbi.nlm.nih.gov/pubmed/35572601
http://dx.doi.org/10.3389/fimmu.2022.869676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092944/
https://www.ncbi.nlm.nih.gov/pubmed/35572601
http://dx.doi.org/10.3389/fimmu.2022.869676

Ejemplares similares